Method | Â | Â | Antigens tested | Â | Â | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Site | No. vol | CSP | TRAP | EXP1 | LSA1 | MSP1 | MSP3 | EBA | Total | Tot/v |
 | Urban | 14 | 2* (14%) | 10 (71%) | 11 (79%) | 12 (86%) | 11 (79%) | 14 (100%) | 8 (57%) | 69 | 4.9 |
 | Rural | 21 | 11 (52%) | 21 (100%) | 19 (90%) | 20 (95%) | 17 (81%) | 20 (95%) | 16 (90%) | 124 | 5.9 |
 | Total | 35 | 13 (37%) | 31 (89%) | 30 (86%) | 32 (91%) | 28 (80%) | 34 (97%) | 24 (86%) | 192 | 5.5 |
2 | Urban | 14 | 0 (0%) | 4 (29%) | 5 (36%) | 12 (86%) | 10 (71%) | 14 (100%) | 2 (14%) | 47 | 3.4 |
 | Rural | 21 | 5 (24%) | 10 (48%) | 10 (48%) | 19 (90%) | 14 (67%) | 19 (90%) | 5 (24%) | 82 | 3.9 |
 | Total | 35 | 5 (14%) | 14 (40%) | 15 (43%) | 31 (89%) | 24 (69%) | 33 (94%) | 7 (20%) | 129 | 3.7 |